These findings are consistent with a scenario in which ETP-ALL arose out of a background of clonal hematopoiesis associated with a heterozygous DNMT3A mutation, a relationship revealed by clearance of ETP-ALL following treatment with BMS-906024 (Fig. 3B). Here, DNMT3A is linked to acute lymphoblastic leukemia.